Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,209,424 | 1,119,599 | 722,884 | 968,086 | 584,128 |
| Marketable Securities | 709,870 | 228,122 | 191,311 | 203,892 | 182,637 |
| Receivables | 1,047,205 | 1,021,369 | 979,802 | 795,127 | 803,628 |
| Inventories | 897,623 | 856,287 | 661,093 | 599,966 | 565,692 |
| Income taxes - deferred | 100,772 | 133,482 | 140,352 | 152,533 | 121,602 |
| Other current assets | 140,791 | 115,194 | 105,439 | 35,242 | 31,602 |
| TOTAL | $4,326,683 | $3,669,377 | $2,948,257 | $3,028,292 | $2,545,043 |
| Non-Current Assets | |||||
| PPE Net | 512,281 | 493,012 | 455,759 | 447,696 | 441,797 |
| Investments And Advances | 1,336,968 | 1,560,631 | 1,674,809 | 1,550,444 | 1,451,286 |
| Intangibles | 0 | 0 | 0 | 0 | 129,898 |
| Other Non-Current Assets | 798,196 | 794,397 | 800,178 | 808,284 | 749,551 |
| TOTAL | $2,647,445 | $2,848,040 | $2,930,746 | $2,806,424 | $2,772,532 |
| Total Assets | $6,974,128 | $6,517,417 | $5,879,003 | $5,834,716 | $5,317,575 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,055 | 3,662 | 216 | 286 | 245 |
| Accounts payable and accrued liabilities | 631,525 | 606,245 | 396,208 | 290,333 | 264,496 |
| Accrued Expenses | 255,232 | 211,807 | 226,646 | 251,688 | 104,176 |
| TOTAL | $1,259,134 | $2,451,334 | $939,005 | $736,275 | $691,439 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,367 | 26,453 | 10,287 | 11,604 | 119,096 |
| Deferred Revenues | 40,205 | 38,764 | 41,174 | 30,747 | 32,562 |
| Other Non-Current Liabilities | 1,473,724 | 211,341 | 1,541,840 | 1,565,531 | 1,461,600 |
| TOTAL | $1,549,084 | $293,858 | $1,610,516 | $1,638,451 | $1,644,291 |
| Total Liabilities | $2,808,218 | $2,745,192 | $2,549,521 | $2,374,726 | $2,335,730 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,821,020 | 1,839,830 | 1,844,939 | 1,857,740 | 1,861,544 |
| Common Shares | 921 | 923 | 921 | 932 | 929 |
| Retained earnings | 531,001 | 265,435 | -34,616 | 249,080 | -121,556 |
| Other shareholders' equity | 17,190 | -11 | -7,931 | -4,363 | -13,515 |
| TOTAL | $4,165,910 | $3,772,225 | $3,329,482 | $3,459,990 | $2,981,845 |
| Total Liabilities And Equity | $6,974,128 | $6,517,417 | $5,879,003 | $5,834,716 | $5,317,575 |